Nucleophilic substitution on α-mesyloxy-O-alkyloximes - I. Enantiospecific synthesis of 2-(imidazol-1-yl) -1,3-diphenylpropan-1-one o-alkyloximes

Tetrahedron Asymmetry

Volumn 8, Issue 2, 1997, Pages 253-263

  Giordani, Antonio ^a   Carera, Alberto ^a   Pinciroli, Vittorio ^a   Cozzi, Paolo ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [1,3 DIPHENYL 2 (IMIDAZOL 1 YL)PROPYLIDENE]AMINOOXYPENTANOIC ACID; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DIASTEREOISOMER; DRUG SYNTHESIS; ENANTIOMER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 0031019842     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(96)00505-8     Document Type: Article

References (24)

1. Cozzi P.; Giordani A.; Menichincheri M.; Pillan A.; Pinciroli V.; Rossi A.; Tonani R.; Volpi D.; Tamburin M.; Ferrario R.; Fusar D.; Salvati P. J. Med. Chem. 1994, 37, 3588-3604.
2. (a) Kagan K. B.; Fiaud J. C. Topics in Stereochem. 1978, 10, 175;
3. (b) Meyers A. I. Acc. Chem. Res. 1978, 11, 375.
4. Enders D. Asymmetric Synthesis 1984, 3, 275-339.
5. Hanessian S. Total Synthesis of Natural Products: The 'Chiron' Approach, Pergamon Press (1983).
6. Reetz M. T.; Drewes M. W.; Lennik K.; Schmitz A.; Holdgrun X. Tetrahedron Asymmetry, 1990, 1, 375-378.
7. (a) Kruse L. T.; Caiser C.; De Wolf W. E.; Frazee J. S.; Garvey E.; Hubert E. L.; Faulkner W. A.; Flaim K. E.; Sawyer J. L.; Berkowitz B. A. J. Med. Chem., 1986, 28, 2465-2472;
8. (b) Cannon W. N.; Powell C. E.; Jones R. G. J. Org. Chem. 1957, 22, 1323-1328.
9. Hoffman R. V.; Jankowsky B. C.; Corr S.; J. Org. Chem., 1986, 51, 130-135;
10. (b) Cristalli G.; Eleutori A.; Volpini R; Vittori S.; Lupidi E. J. Med. Chem. 1994, 37, 201-205.
11. Nahm S.; Weinreb S. M. Tetrahedron Lett. 1981, 22, 3815-3818.
12. Wintz M.; loch-Frankenthal L.; Izumiya N.; Birnbaum S. M.; Baker C. G.; Greenstein J. P. J. Am. Chem. Soc. 1956, 30, 2423-30.
13. Marsman B.; Wynberg H. J. Org. Chem. 1979, 44, 2312-2314.
14. 1H NMR spectroscopy at 400 MHz.
15. Corey E. J.; Dittami J. P. J. Am. Chem. Soc. 1985, 107, 256-257.
16. Dale J. A.; Mosher H. S. J. Am. Chem. Soc. 1973, 95, 512-519.
17. The oxime configuration was assessed on the basis of the down-field deshielding effect (due to the N-O group), or up-field shielding effect (due to the N lone pair), exerted differently by the oxime moiety on the adjacent protons. (a) Karabatsos G. J.; Taller R. A. Tetrahedron 1968, 24, 3347-3360.
18. (b) Karabatsos G.; Hsi N. Tetrahedron 1968, 24, 3347-3360.
19. (c) Karabatsos G. J.; Taller R. A.; Floie G.; Vane A. J. Am. Chem. Soc. 1963, 85, 2327-2328.
20. (d) Mixich V. G.; Thiele K. E. Arzneim-Forsch. 1979, 29, 1510-1513.
21. 1H NMR determination for diastereoisomeric mandelate esters refers to 400 MHz spectra.
22. 16 Ultron ES-OVM column (15 cm×4.6 mm), phosphate buffer (pH 7)/acetonitrile (92/8) was used as eluant, at a flow of 0.8 ml/min.
23. This issue will be addressed in the following paper.
24. Still, W. C.; Kahn, M.; Mitra A. J. Org. Chem. 1978, 43, 2923-2925.